Decreased expression ofBRCA2 mRNA predicts favorable response to docetaxel in breast cancer
- 30 May 2001
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 95 (4) , 255-259
- https://doi.org/10.1002/1097-0215(20010720)95:4<255::aid-ijc1043>3.0.co;2-o
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Acceleration of chromosomal instability by loss of BRCA1 expression and p53 abnormality in sporadic breast cancersCancer Letters, 2000
- Insights into the functions of BRCA1 and BRCA2Trends in Genetics, 2000
- Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancerOncogene, 1999
- Centrosome Amplification and a Defective G2–M Cell Cycle Checkpoint Induce Genetic Instability in BRCA1 Exon 11 Isoform–Deficient CellsMolecular Cell, 1999
- Stable Interaction between the Products of the BRCA1 and BRCA2 Tumor Suppressor Genes in Mitotic and Meiotic CellsMolecular Cell, 1998
- Association of BRCA1 with Rad51 in Mitotic and Meiotic CellsCell, 1997
- BRCA2 mutations in primary breast and ovarian cancersNature Genetics, 1996
- Mutation analysis in the BRCA2 gene in primary breast cancersNature Genetics, 1996
- A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1Science, 1994
- Localization of a Breast Cancer Susceptibility Gene, BRCA2 , to Chromosome 13q12-13Science, 1994